Literature DB >> 4277376

Biochemical abnormalities in Huntington's chorea brains.

W L Stahl, P D Swanson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4277376     DOI: 10.1212/wnl.24.9.813

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  39 in total

Review 1.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

2.  The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.

Authors:  S Consolo; H Ladinsky; S Bianchi; T Caraceni
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-05-16

3.  trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease.

Authors:  Jinrong Fu; Jing Jin; Robert H Cichewicz; Serena A Hageman; Trevor K Ellis; Lan Xiang; Qi Peng; Mali Jiang; Nicolas Arbez; Katelyn Hotaling; Christopher A Ross; Wenzhen Duan
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

Review 4.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

5.  GABA in the caudate nucleus: a possible synaptic transmitter of interneurons.

Authors:  R Spehlmann; K Norcross; E J Grimmer
Journal:  Experientia       Date:  1977-05-15

6.  Regional and subcellular distribution of superoxide dismutase in brain.

Authors:  T C Loomis; G Yee; W L Stahl
Journal:  Experientia       Date:  1976-11-15

Review 7.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

Review 8.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

9.  The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.

Authors:  D M Mann; R Oliver; J S Snowden
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders.

Authors:  F Flentge; W M Hajonides-van Der Meulen; J P Lakke; A W Teelken
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.